CMT Research Foundation Invests in Study Evaluating Potential Therapy for CMTX1
jarmoluk / Pixabay

CMT Research Foundation Invests in Study Evaluating Potential Therapy for CMTX1

Charcot-Marie-Tooth disease (CMT), though rare, is one of the most commonly inherited neurological disorders and affects peripheral nerves outside of the brain and spinal cord. Multiple CMT subtypes exist based…

Continue Reading CMT Research Foundation Invests in Study Evaluating Potential Therapy for CMTX1
Could This Treatment for Ulcerative Colitis and Crohn’s Disease Get Approved in Europe?
source: shutterstock.com

Could This Treatment for Ulcerative Colitis and Crohn’s Disease Get Approved in Europe?

According to reporting from News-Medical.net, Janssen-Cilag International NV recently announced that it had applied for European Medicines Agency (EMA) approval of its drug guselkumab (marketed as TREMFYA) in an expansion…

Continue Reading Could This Treatment for Ulcerative Colitis and Crohn’s Disease Get Approved in Europe?
New FDA Regulation on Laboratory Developed Tests Draws Objections from Healthcare Groups
source: shutterstock.com

New FDA Regulation on Laboratory Developed Tests Draws Objections from Healthcare Groups

As reported in Biopharma Dive, the FDA’s decision to strengthen its authority involving laboratory developed tests (LDTs) has drawn considerable objections from various healthcare groups. However, the Agency has held…

Continue Reading New FDA Regulation on Laboratory Developed Tests Draws Objections from Healthcare Groups

RETINA WORLD CONGRESS: Diabetic Macular Edema Clinical Trials Lack Patient Diversity

When it comes to medical research, diversity, equity, and inclusion need to be larger parts of the conversation. As it stands now, medical research can be fiercely hierarchical, expensive, and homogenous in terms of…

Continue Reading RETINA WORLD CONGRESS: Diabetic Macular Edema Clinical Trials Lack Patient Diversity

Wild Wickenburg Bull Riding Fundraising Raises $5K for Teen with MPGN II

In Wickenburg, Arizona, the community sticks together. Community means strength.  So when Noah Ahnlund was diagnosed with a rare autoimmune disease called membranoproliferative glomerulonephritis type II (MPGN II/dense deposit disease)…

Continue Reading Wild Wickenburg Bull Riding Fundraising Raises $5K for Teen with MPGN II
AOC 1001 Earns Breakthrough Therapy Designation for Myotonic Dystrophy Type 1 (DM1)
source: shutterstock.com

AOC 1001 Earns Breakthrough Therapy Designation for Myotonic Dystrophy Type 1 (DM1)

Currently, there are no approved treatment options for myotonic dystrophy type 1 (DM1), a progressive neuromuscular disease. As the disease progresses, affected individuals experience muscle weakness, respiratory distress, and cardiac…

Continue Reading AOC 1001 Earns Breakthrough Therapy Designation for Myotonic Dystrophy Type 1 (DM1)
New Podcast Episode: The Importance of IPF Clinical Trials, feat. Patient Advocate Murray Walz
source: shutterstock.com

New Podcast Episode: The Importance of IPF Clinical Trials, feat. Patient Advocate Murray Walz

Patient Worthy's award-winning podcast "Wait, How Do You Spell That? A Rare Disease Podcast" is back with a new episode. This week, Colby is sitting down with Murray Walz, a…

Continue Reading New Podcast Episode: The Importance of IPF Clinical Trials, feat. Patient Advocate Murray Walz